Phase 3 EVOKE-01 Study of Sacituzumab Govitecan vs Docetaxel in NSCLC After Prior Platinum and Checkpoint Inhibitors
JOURNAL OF THORACIC ONCOLOGY（2022）
关键词
antibody-drug conjugate, immune checkpoint inhibitors, phase III clinical trial
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要